|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/575 | (2006.01) |
| A61K 31/397 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 3/06 | (2006.01) | ||
| A61P 3/10 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 9/00 | (2006.01) |
| (11) | Number of the document | 3434285 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17769488.2 |
| Date of filing the European patent application | 2017-03-24 | |
| (97) | Date of publication of the European application | 2019-01-30 |
| (45) | Date of publication and mention of the grant of the patent | 2021-06-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2017/078183 |
| Date | 2017-03-24 |
| (87) | Number | WO 2017/162211 |
| Date | 2017-09-28 |
| (30) | Number | Date | Country code |
| 201610173317 | 2016-03-24 | CN |
| (72) |
LIU, Xiaoyu , CN
ZHANG, Faming , CN
CUI, Jian , CN
ZHANG, Sihan , CN
WANG, Huojian , CN
MENG, Yuan , CN
LENG, Zhengwen , CN
QIAN, Lina , CN
|
| (73) |
Waterstone Pharmaceuticals (Wuhan) Co., Ltd. ,
B3-4 Biolake
No. 666 Gaoxin Road
Eastlake National High-Tech Development Zone, Wuhan, Hubei 430075,
CN
|
| (54) | COMBINATIONS OF OBETICHOLIC ACID AND EZETIMIBE FOR THE TREATMENT OF NAFLD AND NASH |
| COMBINATIONS OF OBETICHOLIC ACID AND EZETIMIBE FOR THE TREATMENT OF NAFLD AND NASH |